Literature DB >> 1859820

Folding studies of the cysteine proteinase inhibitor--human stefin A.

E Zerovnik1, B Lenarcic, R Jerala, V Turk.   

Abstract

Reversible GuHCl denaturation of human stefin A (25 degrees C, pH 8) was monitored by the tyrosine fluorescence, by circular dichroism in the near UV and by circular dichroism in the far UV. In each case a midpoint of 2.8 +/- 0.1 M GuHCl was obtained, demonstrating the cooperativity of the denaturation. Kinetics of the slow folding on diluting the protein from the GuHCl denatured state, was also measured by the three spectroscopic probes (10 degrees C, pH 8). Results conform to a sequential mechanism. Denaturant concentration and temperature dependence of the slow folding were measured by fluorescence. From a linear Arrhenius plot the Ea of 100 +/- 5 kJ/mol was read. 'Double mixing' experiments revealed a slow reaction going on in the unfolded state which influenced the amplitude of the fluorescence changes. 'Double mixing' experiments performed by FPLC have shown that the folding itself, i.e., the formation of a compact state, was not dependent on the time spent under unfolding conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1859820     DOI: 10.1016/0167-4838(91)90149-t

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Authors:  Toni Hoffmann; Lukas Kurt Josef Stadler; Michael Busby; Qifeng Song; Anthony T Buxton; Simon D Wagner; Jason J Davis; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2010-02-23       Impact factor: 1.650

2.  Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.

Authors:  E Pol; S L Olsson; S Estrada; T W Prasthofer; I Björk
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.